Search results
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Center for Infectious Disease Research and Policy· 48 minutes agoTaking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19...
Scientists report longest known ‘extreme’ Covid infection in 72-year-old man
The Independent via Yahoo News· 8 hours agoDoctors reported the case of a 72-year-old patient in the Netherlands who suffered from the novel...
How B cells recognize new variants of SARS-CoV-2
Medical Xpress· 1 day agoResearchers at TWINCORE, Center for Clinical and Experimental Infection Research, have now been able to show that the combination of infection and...
Lungs of young adults more susceptible to SARS-CoV-2 virus: Study
Investing.com· 6 days agoLungs of young adults more susceptible to SARS-CoV-2 virus: Study
Engineers muffle invading pathogens with a 'molecular mask'
Phys.org· 2 hours agoThe peptides that make up this gel prevent viruses such as SARS-CoV-2, which causes COVID-19, from attaching to and entering cells. Over ...
JN.1 COVID Variant Symptoms vs. Allergy Symptoms
Verywell Health via Yahoo News· 2 days agoThe JN.1 COVID variant has slightly different symptoms than other variants, as well as some differences when compared to seasonal allergies. Here's what...
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
SciTechDaily· 2 days agoThe SARS-CoV-2 virus that causes COVID has the unsettling ability of often generating variants of...
Physicist Studying SARS-CoV-2 Virus Believes He Has Found Hints We Are Living In A Simulation
IFLScience· 1 week agoA physicist studying mutations of the SARS-CoV-2 virus claims to have found evidence for a new law...
Loss Of Smell Might Persist Even One Year After A Covid-19 Infection
Forbes· 12 hours agoThe latter is due to molecules reaching the olfactory receptors from the oral cavity via the...
COVID Shot Boosts Mucosal Immunity in Previously Infected People
MedPage Today· 1 day agoOnly 'traces' of spike-specific salivary antibodies found in vaccinated SARS-CoV-2-naive people